Annette Bruchfeld
Annette Bruchfeld
Professor, Renal Medicine, Linköping University and Karolinska Institutet
Verifierad e-postadress på ki.se
Citeras av
Citeras av
Genetically distinct subsets within ANCA-associated vasculitis
PA Lyons, TF Rayner, S Trivedi, JU Holle, RA Watts, DRW Jayne, ...
New England Journal of Medicine 367 (3), 214-223, 2012
Grazoprevir plus elbasvir in treatment-naive and treatment-experienced patients with hepatitis C virus genotype 1 infection and stage 4–5 chronic kidney disease (the C-SURFER …
D Roth, DR Nelson, A Bruchfeld, AM Liapakis, M Silva, H Monsour Jr, ...
The Lancet 386 (10003), 1537-1545, 2015
Pulse versus daily oral cyclophosphamide for induction of remission in ANCA-associated vasculitis: long-term follow-up
L Harper, MD Morgan, M Walsh, P Hoglund, K Westman, O Flossmann, ...
Annals of the rheumatic diseases 71 (6), 955-960, 2012
Randomized trial of C5a receptor inhibitor avacopan in ANCA-associated vasculitis
DRW Jayne, AN Bruchfeld, L Harper, M Schaier, MC Venning, P Hamilton, ...
Journal of the American Society of Nephrology 28 (9), 2756-2767, 2017
Elevated high-mobility group box 1 levels in patients with cerebral and myocardial ischemia
RS Goldstein, M Gallowitsch-Puerta, LH Yang, M Rosas-Ballina, ...
Shock 25 (6), 571-574, 2006
High‐dose ribavirin in combination with standard dose peginterferon for treatment of patients with chronic hepatitis C
K Lindahl, L Stahle, A Bruchfeld, R Schvarcz
Hepatology 41 (2), 275-279, 2005
Cholinergic anti-inflammatory pathway activity and High Mobility Group Box-1 (HMGB1) serum levels in patients with rheumatoid arthritis
RS Goldstein, A Bruchfeld, L Yang, AR Qureshi, M Gallowitsch-Puerta, ...
Molecular medicine 13 (3), 210-215, 2007
Plasma exchange for renal vasculitis and idiopathic rapidly progressive glomerulonephritis: a meta-analysis
M Walsh, F Catapano, W Szpirt, K Thorlund, A Bruchfeld, L Guillevin, ...
American Journal of Kidney Diseases 57 (4), 566-574, 2011
Interferon and ribavirin treatment in patients with hepatitis C-associated renal disease and renal insufficiency
A Bruchfeld, K Lindahl, L Ståhle, M Söderberg, R Schvarcz
Nephrology Dialysis Transplantation 18 (8), 1573-1580, 2003
Ribavirin treatment in dialysis patients with chronic hepatitis C virus infection–a pilot study
A Bruchfeld, L Ståhle, J Andersson, R Schvarcz
Journal of Viral Hepatitis 8 (4), 287-292, 2001
Pegylated interferon and ribavirin treatment for hepatitis C in haemodialysis patients
A Bruchfeld, K Lindahl, O Reichard, T Carlsson, R Schvarcz
Journal of viral hepatitis 13 (5), 316-321, 2006
Dosage of ribavirin in patients with hepatitis C should be based on renal function: a population pharmacokinetic analysis
A Bruchfeld, K Lindahl, R Schvarcz, L Ståhle
Therapeutic drug monitoring 24 (6), 701-708, 2002
Hepatitis C infection, time in renal-replacement therapy, and outcome after kidney transplantation
A Bruchfeld, H Wilczek, CG Elinder
Transplantation 78 (5), 745-750, 2004
Mycophenolate mofetil versus cyclophosphamide for remission induction in ANCA-associated vasculitis: a randomised, non-inferiority trial
RB Jones, TF Hiemstra, J Ballarin, DE Blockmans, P Brogan, A Bruchfeld, ...
Annals of the rheumatic diseases 78 (3), 399-405, 2019
Whole blood cytokine attenuation by cholinergic agonists ex vivo and relationship to vagus nerve activity in rheumatoid arthritis
A Bruchfeld, RS Goldstein, S Chavan, NB Patel, M Rosas‐Ballina, N Kohn, ...
Journal of internal medicine 268 (1), 94-101, 2010
High mobility group box protein-1 correlates with renal function in chronic kidney disease (CKD)
A Bruchfeld, AR Qureshi, B Lindholm, P Barany, LH Yang, P Stenvinkel, ...
Molecular medicine 14 (3), 109-115, 2008
Evidence that plasma concentration rather than dose per kilogram body weight predicts ribavirin‐induced anaemia
K Lindahl, R Schvarcz, A Bruchfeld, L Ståhle
Journal of viral hepatitis 11 (1), 84-87, 2004
Deoxyspergualin in relapsing and refractory Wegener’s granulomatosis
O Flossmann, B Baslund, A Bruchfeld, JWC Tervaert, C Hall, P Heinzel, ...
Annals of the rheumatic diseases 68 (7), 1125-1130, 2009
Renal expression and serum levels of high mobility group box 1 protein in lupus nephritis
A Zickert, K Palmblad, B Sundelin, S Chavan, KJ Tracey, A Bruchfeld, ...
Arthritis research & therapy 14 (1), 1-10, 2012
Outcome and treatment of elderly patients with ANCA-associated vasculitis
M Weiner, SM Goh, AJ Mohammad, Z Hruskova, A Tanna, A Bruchfeld, ...
Clinical journal of the American society of nephrology 10 (7), 1128-1135, 2015
Systemet kan inte utföra åtgärden just nu. Försök igen senare.
Artiklar 1–20